JP Morgan Chase’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.5M | Sell |
99,105
-35,519
| -26% | -$9.45M | ﹤0.01% | 1917 |
|
|
2025
Q4 | $33.2M | Sell |
134,624
-11,730
| -8% | -$2.47M | ﹤0.01% | 1648 |
|
|
2025
Q3 | $25.8M | Buy |
146,354
+55,201
| +61% | +$8.26M | ﹤0.01% | 1894 |
|
|
2025
Q2 | $12.5M | Sell |
91,153
-9,621
| -10% | -$1.41M | ﹤0.01% | 2348 |
|
|
2025
Q1 | $18.2M | Sell |
100,774
-51,061
| -34% | -$8.59M | ﹤0.01% | 2006 |
|
|
2024
Q4 | $23.8M | Buy |
151,835
+23,934
| +19% | +$4.25M | ﹤0.01% | 1878 |
|
|
2024
Q3 | $23.3M | Sell |
127,901
-35,923
| -22% | -$6.93M | ﹤0.01% | 1861 |
|
|
2024
Q2 | $30.1M | Sell |
163,824
-11,302
| -6% | -$1.9M | ﹤0.01% | 1554 |
|
|
2024
Q1 | $31.2M | Sell |
175,126
-38,393
| -18% | -$5.33M | ﹤0.01% | 1578 |
|
|
2023
Q4 | $26.5M | Sell |
213,519
-7,974
| -4% | -$884K | ﹤0.01% | 1624 |
|
|
2023
Q3 | $25.7M | Sell |
221,493
-18,290
| -8% | -$2.23M | ﹤0.01% | 1496 |
|
|
2023
Q2 | $28.2M | Buy |
239,783
+1,374
| +0.6% | +$140K | ﹤0.01% | 1451 |
|
|
2023
Q1 | $19.1M | Buy |
238,409
+472
| +0.2% | +$37.1K | ﹤0.01% | 1700 |
|
|
2022
Q4 | $18.8M | Sell |
237,937
-4,756
| -2% | -$353K | ﹤0.01% | 1721 |
|
|
2022
Q3 | $16.9M | Sell |
242,693
-15,874
| -6% | -$1.15M | ﹤0.01% | 1700 |
|
|
2022
Q2 | $17M | Buy |
258,567
+706
| +0.3% | +$43.9K | ﹤0.01% | 1734 |
|
|
2022
Q1 | $17.2M | Buy |
257,861
+58,228
| +29% | +$3.63M | ﹤0.01% | 1907 |
|
|
2021
Q4 | $14M | Sell |
199,633
-24,786
| -11% | -$1.44M | ﹤0.01% | 2138 |
|
|
2021
Q3 | $11.7M | Sell |
224,419
-186,462
| -45% | -$11M | ﹤0.01% | 2246 |
|
|
2021
Q2 | $27.9M | Buy |
410,881
+26,603
| +7% | +$1.86M | ﹤0.01% | 1568 |
|
|
2021
Q1 | $29.6M | Buy |
384,278
+144,966
| +61% | +$10.5M | ﹤0.01% | 1453 |
|
|
2020
Q4 | $14.4M | Buy |
239,312
+153,490
| +179% | +$7.67M | ﹤0.01% | 1903 |
|
|
2020
Q3 | $3.62M | Buy |
85,822
+18,223
| +27% | +$791K | ﹤0.01% | 2821 |
|
|
2020
Q2 | $2.8M | Buy |
67,599
+20,954
| +45% | +$1.01M | ﹤0.01% | 2879 |
|
|
2020
Q1 | $2.02M | Buy |
46,645
+26,892
| +136% | +$1.41M | ﹤0.01% | 2958 |
|
|
2019
Q4 | $1.09M | Buy |
19,753
+16,312
| +474% | +$800K | ﹤0.01% | 3782 |
|
|
2019
Q3 | $119K | Sell |
3,441
-16,065
| -82% | -$718K | ﹤0.01% | 4829 |
|
|
2019
Q2 | $741K | Buy |
19,506
+12,891
| +195% | +$421K | ﹤0.01% | 4024 |
|
|
2019
Q1 | $218K | Buy |
6,615
+5,402
| +445% | +$127K | ﹤0.01% | 4600 |
|
|
2018
Q4 | $25K | Sell |
1,213
-34,920
| -97% | -$731K | ﹤0.01% | 5280 |
|
|
2018
Q3 | $635K | Buy |
36,133
+14,755
| +69% | +$248K | ﹤0.01% | 4171 |
|
|
2018
Q2 | $318K | Buy |
+21,378
| New | +$240K | ﹤0.01% | 4372 |
|
Other funds holding KRYS
ACA
VPM
VCM
SCM
RG
